Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans (Q34705107)

4 August 2017

title

Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans (English)

1 reference

4 August 2017

Kyle O Arneson

1

1 reference

4 August 2017

L Jackson Roberts

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

4 August 2017

published in

Methods in Enzymology

1 reference

4 August 2017

volume

433

1 reference

4 August 2017

page(s)

127-143

1 reference

Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Essential Fatty Acids: The Importance of n-3 Fatty Acids in the Retina and Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

The measurement of free radical reactions in humans. Some thoughts for future experimentation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Role of free radicals and catalytic metal ions in human disease: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

The isoprostanes: unique bioactive products of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Fish intake, contaminants, and human health: evaluating the risks and the benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Mitochondrial dysfunction in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

Docosahexaenoic acid: membrane properties of a unique fatty acid

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2933007-3

7 January 2021

10.1016/S0076-6879(07)33007-3

Identifiers

DOI

1 reference

4 August 2017

1 reference